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Aldosterone-Producing Adrenocortical Carcinoma without 
Hypertension
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Although adrenocortical tumors are common, adrenocortical carcinomas are rare. Moreover, aldosterone-producing 
adrenocortical carcinomas without hypertension are exceedingly rare, with only two previously reported cases.
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INTRODUCTION
Primary aldosteronism is a syndrome characterized 
by hypertension and hypokalemia [1]. Aldosterone-
producing adenomas (APAs) and bilateral idiopathic 
hyperaldosteronism (IHA) are the most common causes 
of primary aldosteronism, with APA accounting for ap-
proximately 35% of the cases, and IHA accounting for 
60% [2]. Aldosterone-producing adrenocortical carci-
nomas (APACs) are a very rare cause of primary aldo-
steronism [3]. As a cause of primary aldosteronism, an 
APAC is characterized by hypertension and hypokale-
mia [3]; however, very few APACs have features of nor-
motensive primary aldosteronism [4,5]. Here, we report 
a case of APAC without hypertension.
CASE REPORT
A 32-year-old woman was referred to our hospital for 
evaluation of a left adrenal mass. She had undergone 
an appendectomy 2 weeks earlier, and the mass was 
diagnosed incidentally on postoperative abdominal ul-
trasonography. On admission, her blood pressure was 
110/70 mmHg, and her pulse was 80 beats/min. Serial 
blood pressures during her hospital stay ranged from 
110/70 to 130/80 mmHg. The patient had hypokale-
mia (2.5 mmol/L) and was started on spironolactone 
(100 mg twice daily) and oral potassium chloride. The 
plasma aldosterone level was 389.53 pg/mL (normal 
range, 10.0 to 105) in the supine position and 716.87 
pg/mL in the upright position (normal range, 34.0 to 
273.0). Plasma rennin activity was 0.1 nmol/L/hr. Com-
puted tomography showed a solid, homogenous adrenal 
mass with a maximum diameter of 42 mm (Fig. 1). An 
adrenalectomy with lymphadenectomy was performed. 
The tumor was an ill-defined, gray-tan solid mass mea-
suring 42 × 33 × 22 mm (Fig. 2). Histopathologically, it 
consisted of a solid nest of bland to anaplastic cells with 
frequent mitoses and necrosis (Fig. 2). Her potassium 
level normalized on postoperative day 7 without potas-
sium supplements or spironolactone.222    The Korean journal of Internal Medicine Vol. 27, No. 2, june 2012
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DISCUSSION
In approximately 60% of cases, an adrenocortical 
carcinoma presents with evidence of adrenal steroid 
hormone excess [6], while APACs are exceedingly rare. 
To our knowledge, only 59 cases have been reported, in-
cluding our case [3]. An APAC is usually associated with 
hypokalemia, renal potassium leakage, and arterial 
hypertension due to excessive aldosterone secretion. 
A few specific symptoms such as muscle weakness and 
cramping, headache, palpitations, polydipsia, polyuria, 
and nocturia, or a combination of these symptoms, may 
be present in cases of marked hypokalemia [7]. Patients 
with suspected primary aldosteronism can be screened 
by measuring the morning ambulatory paired random 
plasma aldosterone concentration and plasma renin 
activity [2]. However, several studies have shown that 
most patients with primary aldosteronism have base-
line blood potassium levels in the normal range [8,9]. 
Consequently, hypokalemia is not used to establish the 
diagnosis of primary aldosteronism, and an increased 
ratio of plasma aldosterone concentration to plasma re-
nin activity is not diagnostic in itself [2]. Primary aldo-
steronism can be confirmed by an oral sodium loading 
test, an intravenous saline infusion test, or a fludrocor-
tisone suppression test [2].
An APAC is a rare cause of primary aldosteronism. 
Typically, a patient with an APAC has features of prima-
ry aldosteronism, including hypertension and hypokale-
mia. Nevertheless, two of the 58 reported APAC patients 
Figure 1. Abdominal computed tomography reveals a solid, 
homogenous 42 × 33-mm adrenal mass (arrow).
Table 1. Clinical features of the three cases of aldosterone-producing adrenocortical carcinoma without hypertension
Characteristic Muthusethupathi et al. [4] Yamazaki et al. [5] Current case
Age, yr 40 25 32
Gender Male Male Female
Race No data japanese Korean
Blood pressure, mmHg 90/70-120/80 120/80 110/70-130/80
Potassium, mmol/L 2.3 2.1 2.5
Aldosterone, pg/mL 1,170-1,290 (50-200) > 4,000 (7-12) 389-716 (10-273)
Plasma renin activity, nmol/L/hr 0.7 0.3 0.1
Tumor size, mm 56 × 60 ND 42 × 33
Site  Right Left Left
Lymph node metastasis Positive ND Positive
Other adrenal hormones Not increased Not increased Not increased
Postoperative stay, day 15 ND 7
ND, not descriptive.
Figure 2. Histopathologically, the aldosterone-producing 
adrenocortical carcinoma shows solid nests of bland to anaplastic 
cells, with frequent mitoses and necrosis (H&E, × 400).Song MS, et al. Normotensive aldosterone-producing adrenal carcinoma   223
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had normal blood pressure [3]. The two cases of APAC 
without hypertension were reported by Muthusethu-
pathi et al. [4] and Yamazaki et al. [5] Information on 
these two published cases and our case is summarized 
in Table 1.
Vantyghem et al. [7] presented two cases of APA with-
out hypertension; including these two cases, 18 cases of 
normotensive primary hyperaldosteronism have been 
reported. Only 10 of these cases have been published 
in the English literature, and about 75% of cases have 
been reported in Eurasians. Of the three cases listed in 
Table 1, one patient was Japanese, and another patient 
was Korean; no information was available regarding the 
third.
The normal blood pressure in these rare cases of pri-
mary aldosteronism is not fully understood, and various 
explanations have been offered, including an absence 
of volume expansion, a low-salt diet, abnormal atrial 
natriuretic peptide activity, and the use of glucocor-
ticoids [7]. The patients might have been hypotensive 
before the onset of the disease, might have experienced 
a blunted response to pressor agents, or might have ex-
hibited associated hypopituitarism [4]. The exact cause 
of this disease in our patient remains unknown.
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